Professional Practice » ICHP Position Statements »

The Illinois Council of Health-System Pharmacists (ICHP) supports FDA regulation of the herbal product industry with adequate resources to do so effectively. ICHP also recommends that manufacturers of herbal and alternative substances be required to provide substantial proof of efficacy and safety prior to marketing approval.
ICHP encourages pharmacy practitioners to become adequately educated about herbal and alternative substances. Such substances should be included in documenting medication histories, during pre-surgery planning and as part of comprehensive patient counseling. ICHP also supports a system for routine monitoring and reporting of herbal and alternative substances defects, adulteration, identified interactions, and adverse effects through recognized reporting mechanisms, such as the FDA MedWatch program.
Revised 08/2010
© 2012 ICHP All Rights Reserved.
Home | About | Contact | Privacy Policy | Terms & Conditions | Advertising